5,446
Participants
Start Date
June 30, 2009
Study Completion Date
December 31, 2011
EE30/DRSP (Yasmin, BAY86-5131)
Patients under regular daily life treatment receiving Yasmin according to local drug information
Any other OC
Patients under regular daily life treatment receiving any other OC according to local drug information
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY